Pfizer's (PFE.US) $43 billion Seagen (SGEN.US) deal wins unconditional EU approval. As it was concluded by European lawmakers, deal wouldn't raise competition concerns or higher prices for oncology drugs.
Source: xStation5
Pfizer's (PFE.US) $43 billion Seagen (SGEN.US) deal wins unconditional EU approval. As it was concluded by European lawmakers, deal wouldn't raise competition concerns or higher prices for oncology drugs.
Source: xStation5
U.S. indices ended the week on an optimistic note. At today's session opening, there was a rise primarily in smaller-cap companies. However,...
18:24Charter Communications (CHTR.US) stock is up nearly 17% in today's session after the company reported second-quarter results that exceeded analysts'...
18:12Investors will have a lot to digest next week as the calendar is filled with major events! Traders will receive interest rate decisions from 3 major central...